Adopting an approach that encourages continued progress while simultaneously acknowledging short-term obstacles, the Healthcare Information and Management Systems Society (HIMSS) recommends launching Stage 2 Meaningful Use on-schedule and extending Year 1 of the Meaningful Use Stage 2 attestation period through April 2015 and June 2015 for eligible hospitals (EHs) and eligible professionals (EPs), respectively. This would encompass 18 months in which EHs and EPs can attest to Meaningful Use requirements for one quarter.
Boston Scientific Corp. has completed enrollment in the SuperNOVA trial – a global, single arm, prospective, multicenter clinical trial evaluating the long-term (12-month) safety and effectiveness of the Innova Self-Expanding Stent System (Innova Stent System). This stent system is designed for treating patients with a narrowing or blockage of the arteries above the knee, often associated with peripheral artery disease (PAD).
Baptist Health eliminated 85 percent of CDs by storing and sharing medical images in real-time through Accelarad’s secure cloud platform. As central Alabama’s healthcare leader and one of only five Level II trauma facilities in the state, Baptist Health has been an Accelarad customer since March 2013.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
At the opening session of the third annual Amputation Prevention Symposium (AMP) in Chicago, Mary L. Yost, president of The Sage Group, delivered a lecture titled “Amputation Is It Really Cost-Effective.”
Frost & Sullivan has named Siemens Healthcare the "2013 North American Interventional Radiology Company of the Year" for its interventional imaging solutions in cardiology, radiology and hybrid surgery. The Frost & Sullivan study states, "Siemens is extremely well positioned within the interventional cardiology segment, within the overarching surgical clinical segment, as well as neurology, oncology and pediatrics." Siemens says it has been able to sustain market expansion momentum by continually leading the industry in the development of new technology for high-end interventional equipment, while enhancing current clinical applications and enabling new ones. Over the last decade, Siemens said it has succeeded in establishing the company as the market and technology leader in the United States by exploring new possibilities to enhance interventional therapy and patient care.
August 22, 2013 — The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 22, 2013 – BioVentrix announced the successful first use of its Revivent Myocardial Anchoring System via the Less Invasive Ventricular Enhancement (LIVE) procedure in Germany. The successful procedure was performed on a 54-year-old man suffering from advanced heart failure at the Schön Klinik Vogtareuth in Vogtareuth, Germany.
Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology department, wants to get to the bottom of two cardiovascular diseases: hypertension and congestive heart failure.
The U.S. Food and Drug Administration (FDA) approved Boston Scientific’s IntellaTip MiFi XP catheter and granted 510(k) clearance for the Zurpaz 8.5 French steerable sheath for electrophysiology (EP) ablation procedures.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The idea that surgery to relieve the pressure caused by hemorrhaging in the brain is a perfect job for a robotic system is the basic premise of a new image-guided surgical system under development at Vanderbilt University. It employs steerable needles about the size of those used for biopsies to penetrate the brain with minimal damage and suction away the blood clot that has formed.
August 20, 2013 — St. Jude Medical Inc. announced the acquisition of Endosense SA, a Switzerland-based company that has pioneered contact-force measurement in catheter ablation. The acquisition adds to the company’s electrophysiology portfolio and provides a robust platform for future product development.
Cardiac surgeons and cardiologists at the University of Maryland Heart Center are part of a multi-center clinical trial evaluating the efficacy of powering heart pumps through a skull-based connector behind the ear. Typically, these devices for patients with severe heart failure are energized through an electrical cord connected at an abdominal site.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 19, 2013 — Medtronic Inc. announced the submission of its first pre-market approval (PMA) module to the U.S. Food and Drug Administration (FDA) for the IN.PACT Admiral drug-eluting balloon.
Cook Medical is again shipping its Zilver PTX drug-eluting peripheral stent to medical centers in the United States, Japan, Europe and other major markets. The shipments follow a brief period of unavailability due to a voluntary recall by Cook related to an issue with the stent’s delivery catheter that has been resolved.
IMRIS Inc. announced that a craniotomy recently performed on a 5-year-old boy with epilepsy was the 500th neurosurgical case at Cook Children's Medical Center in Fort Worth, Texas, using its intraoperative magnetic resonance imaging (iMRI) system. Cook Children's was the second children's hospital in the United States and fourth hospital worldwide with an IMRIS system that features a high-field MRI, which moves between surgical and diagnostic rooms using ceiling-mounted rails.